FDA Approved: * August 9, 2007 Pharm Company: *ABRAXIS PHARM Category:Antibiotics
Cefotetan is an injectable antibiotic of the cephamycin type for prophylaxis and treatment of bacterial infections. It is often grouped together with second-generation cephalosporins and has a similar antibacterial spectrum, but with additional anti-anaerobe coverage.
Cefotetan was developed by Yamanouchi. It is marketed outside Japan by AstraZeneca with the brand names Apatef and Cefotan.
1 Adverse effects
2 Spectrum of bacterial susceptibility
4 External links
* May have multiple approval dates, manufacturers, or labelers.
Cefotetan 1 g/1 Intramuscular; Intravenous Injection, Powder, for Solution